These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 30189273)

  • 1. Physiologically based pharmacokinetic modelling to guide drug delivery in older people.
    Chetty M; Johnson TN; Polak S; Salem F; Doki K; Rostami-Hodjegan A
    Adv Drug Deliv Rev; 2018 Oct; 135():85-96. PubMed ID: 30189273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virtual bioequivalence for achlorhydric subjects: The use of PBPK modelling to assess the formulation-dependent effect of achlorhydria.
    Doki K; Darwich AS; Patel N; Rostami-Hodjegan A
    Eur J Pharm Sci; 2017 Nov; 109():111-120. PubMed ID: 28774813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiologically-based PK/PD modelling of therapeutic macromolecules.
    Thygesen P; Macheras P; Van Peer A
    Pharm Res; 2009 Dec; 26(12):2543-50. PubMed ID: 19847627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a Whole-Body Physiologically Based Pharmacokinetic Approach to Assess the Pharmacokinetics of Drugs in Elderly Individuals.
    Schlender JF; Meyer M; Thelen K; Krauss M; Willmann S; Eissing T; Jaehde U
    Clin Pharmacokinet; 2016 Dec; 55(12):1573-1589. PubMed ID: 27351180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coupled in silico platform: Computational fluid dynamics (CFD) and physiologically-based pharmacokinetic (PBPK) modelling.
    Vulović A; Šušteršič T; Cvijić S; Ibrić S; Filipović N
    Eur J Pharm Sci; 2018 Feb; 113():171-184. PubMed ID: 29054499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PBPK models for the prediction of in vivo performance of oral dosage forms.
    Kostewicz ES; Aarons L; Bergstrand M; Bolger MB; Galetin A; Hatley O; Jamei M; Lloyd R; Pepin X; Rostami-Hodjegan A; Sjögren E; Tannergren C; Turner DB; Wagner C; Weitschies W; Dressman J
    Eur J Pharm Sci; 2014 Jun; 57():300-21. PubMed ID: 24060672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integration of dissolution into physiologically-based pharmacokinetic models III: PK-Sim®.
    Willmann S; Thelen K; Lippert J
    J Pharm Pharmacol; 2012 Jul; 64(7):997-1007. PubMed ID: 22686345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opportunities and challenges of physiologically based pharmacokinetic modeling in drug delivery.
    Wang W; Ouyang D
    Drug Discov Today; 2022 Aug; 27(8):2100-2120. PubMed ID: 35452792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel strategy for physiologically based predictions of human pharmacokinetics.
    Jones HM; Parrott N; Jorga K; Lavé T
    Clin Pharmacokinet; 2006; 45(5):511-42. PubMed ID: 16640456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing pharmacokinetic bridging studies in paediatric oncology using physiologically-based pharmacokinetic modelling: application to docetaxel.
    Thai HT; Mazuir F; Cartot-Cotton S; Veyrat-Follet C
    Br J Clin Pharmacol; 2015 Sep; 80(3):534-47. PubMed ID: 26095234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of physiologically based pharmacokinetic (PBPK) modeling in oncology drug development and its accuracy: a systematic review.
    Saeheng T; Na-Bangchang K; Karbwang J
    Eur J Clin Pharmacol; 2018 Nov; 74(11):1365-1376. PubMed ID: 29978293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using Physiologically Based Pharmacokinetic (PBPK) Modelling to Gain Insights into the Effect of Physiological Factors on Oral Absorption in Paediatric Populations.
    Villiger A; Stillhart C; Parrott N; Kuentz M
    AAPS J; 2016 Jul; 18(4):933-47. PubMed ID: 27060007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiologically Based Pharmacokinetic Modelling and Prediction of Metformin Pharmacokinetics in Renal/Hepatic-Impaired Young Adults and Elderly Populations.
    Rhee SJ; Chung H; Yi S; Yu KS; Chung JY
    Eur J Drug Metab Pharmacokinet; 2017 Dec; 42(6):973-980. PubMed ID: 28536774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting human exposure of active drug after oral prodrug administration, using a joined in vitro/in silico-in vivo extrapolation and physiologically-based pharmacokinetic modeling approach.
    Malmborg J; Ploeger BA
    J Pharmacol Toxicol Methods; 2013; 67(3):203-13. PubMed ID: 23280406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural and functional pharmacokinetic analogs for physiologically based pharmacokinetic (PBPK) model evaluation.
    Ellison CA
    Regul Toxicol Pharmacol; 2018 Nov; 99():61-77. PubMed ID: 30201539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The emerging role of physiologically based pharmacokinetic modelling in solid drug nanoparticle translation.
    Siccardi M; Rannard S; Owen A
    Adv Drug Deliv Rev; 2018 Jun; 131():116-121. PubMed ID: 29959958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in experimental and mechanistic computational models to understand pulmonary exposure to inhaled drugs.
    Bäckman P; Arora S; Couet W; Forbes B; de Kruijf W; Paudel A
    Eur J Pharm Sci; 2018 Feb; 113():41-52. PubMed ID: 29079338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating Islatravir Administered Via Microneedle Array Patch for Long-Acting HIV Pre-exposure Prophylaxis Using Physiologically Based Pharmacokinetic Modelling.
    Kinvig H; Cottura N; Lloyd A; Frivold C; Mistilis J; Jarrahian C; Siccardi M
    Eur J Drug Metab Pharmacokinet; 2022 Nov; 47(6):855-868. PubMed ID: 36178586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physiologically based pharmacokinetic modelling of lisinopril in children: A case story of angiotensin converting enzyme inhibitors.
    Xie F; Van Bocxlaer J; Vermeulen A
    Br J Clin Pharmacol; 2021 Mar; 87(3):1203-1214. PubMed ID: 32693432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current use and future potential of (physiologically based) pharmacokinetic modelling of radiopharmaceuticals: a review.
    Siebinga H; de Wit-van der Veen BJ; Stokkel MDM; Huitema ADR; Hendrikx JJMA
    Theranostics; 2022; 12(18):7804-7820. PubMed ID: 36451855
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.